- Home
- SUPN vs CXM Comparison
SUPN vs CXM Comparison
Compare SUPN & CXM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- CXM
- Stock Information
- Founded
- SUPN 2005
- CXM 2009
- Country
- SUPN United States
- CXM United States
- Employees
- SUPN N/A
- CXM N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- CXM Computer Software: Prepackaged Software
- Sector
- SUPN Health Care
- CXM Technology
- Exchange
- SUPN Nasdaq
- CXM Nasdaq
- Market Cap
- SUPN 1.9B
- CXM 1.8B
- IPO Year
- SUPN 2012
- CXM 2021
- Fundamental
- Price
- SUPN $35.57
- CXM $7.67
- Analyst Decision
- SUPN Hold
- CXM Hold
- Analyst Count
- SUPN 1
- CXM 13
- Target Price
- SUPN $36.00
- CXM $9.68
- AVG Volume (30 Days)
- SUPN 422.4K
- CXM 3.1M
- Earning Date
- SUPN 11-04-2024
- CXM 12-04-2024
- Dividend Yield
- SUPN N/A
- CXM N/A
- EPS Growth
- SUPN 130.79
- CXM 566.50
- EPS
- SUPN 1.07
- CXM 0.17
- Revenue
- SUPN $651,972,000.00
- CXM $773,698,000.00
- Revenue This Year
- SUPN $7.82
- CXM $8.44
- Revenue Next Year
- SUPN N/A
- CXM $4.31
- P/E Ratio
- SUPN $33.25
- CXM $44.94
- Revenue Growth
- SUPN 6.79
- CXM 14.72
- 52 Week Low
- SUPN $25.53
- CXM $6.91
- 52 Week High
- SUPN $39.37
- CXM $17.14
- Technical
- Relative Strength Index (RSI)
- SUPN 53.46
- CXM 51.09
- Support Level
- SUPN $35.87
- CXM $7.47
- Resistance Level
- SUPN $39.37
- CXM $8.33
- Average True Range (ATR)
- SUPN 1.69
- CXM 0.33
- MACD
- SUPN 0.03
- CXM 0.05
- Stochastic Oscillator
- SUPN 36.03
- CXM 47.20
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The Company's diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About CXM Sprinklr Inc.
Sprinklr Inc is engaged in providing enterprise software that enables every customer-facing function across the front office, from Customer Care to Marketing, to collaborate across internal silos, and communicate across digital channels. Its products include Sprinklr Service, Sprinklr Social, Sprinklr Insights and Sprinklr Marketing. The company operates in Americas, EMEA and other countries. It derives maximum revenue from Americas.